Amphastar Pharma (AMPH)
23.79 x 1 31.40 x 2
Pre-market by (Cboe BZX)
24.41 -0.09 (-0.37%) 04/30/25 [NASDAQ]
23.79 x 1 31.40 x 2
Pre-market 24.41 unch (unch) 16:00 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select FieldsSymbol | AMPH | SUPN | TSHA | ||
Company | Amphastar Pharma | Supernus Pharm | Taysha Gene Therapies Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 24.44 | 32.60 | 1.7800 | ||
High | 24.51 | 32.80 | 1.9800 | ||
Low | 23.91 | 32.15 | 1.7800 | ||
Last | 24.41 | 32.48 | 1.9400 | ||
Change | -0.09 | -0.01 | +0.1200 | ||
% Change | -0.37% | -0.03% | +6.59% | ||
Volume | 460,100 | 283,700 | 1,030,200 | ||
20-Day Average Volume | 631,355 | 531,230 | 1,941,910 | ||
Previous Close | 24.50 | 32.49 | 1.8200 | ||
Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 24.51 | 31.64 | 1.4473 | ||
20-Day Raw Stochastic | 31.33% | 60.32% | 95.70% | ||
20-Day Relative Strength | 39.77% | 51.03% | 62.19% | ||
Weighted Alpha | -49.61 | +2.44 | -22.00 | ||
Today's Opinion | 100% Sell | 56% Sell | 8% Sell | ||
Previous Opinion | 100% Sell | 56% Sell | 40% Sell | ||
Last Month's Opinion | 88% Sell | 40% Sell | 80% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +3.61% since 04/23/25 | +5.32% since 04/23/25 | +6.59% since 04/23/25 | ||
Low | 23.35 on 04/24/25 | 30.42 on 04/24/25 | 1.7000 on 04/25/25 | ||
High | 24.61 on 04/29/25 | 32.80 on 04/30/25 | 1.9800 on 04/30/25 | ||
1-Month | |||||
%Chg | -14.14% since 03/28/25 | +0.59% since 03/28/25 | +0.52% since 03/28/25 | ||
Low | 22.64 on 04/16/25 | 29.77 on 04/09/25 | 1.0500 on 04/09/25 | ||
High | 29.27 on 04/01/25 | 34.26 on 04/07/25 | 1.9800 on 04/30/25 | ||
3-Month | |||||
%Chg | -32.88% since 01/30/25 | -16.05% since 01/30/25 | +31.08% since 01/30/25 | ||
Low | 22.64 on 04/16/25 | 29.77 on 04/09/25 | 1.0500 on 04/09/25 | ||
High | 36.35 on 01/31/25 | 40.28 on 02/05/25 | 1.9800 on 04/30/25 | ||
6-Month | |||||
%Chg | -51.93% since 10/30/24 | -6.85% since 10/30/24 | +3.74% since 10/30/24 | ||
Low | 22.64 on 04/16/25 | 29.77 on 04/09/25 | 1.0500 on 04/09/25 | ||
High | 53.96 on 11/06/24 | 40.28 on 02/05/25 | 3.3100 on 12/02/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,159,524 | 1,812,839 | 397,807 | ||
Shares Outstanding, K | 47,502 | 55,814 | 205,055 | ||
Annual Sales | 731,970,000 | 661,820,000 | 8,330,000 | ||
Annual Net Income | 159,520,000 | 73,870,000 | -89,300,000 | ||
Last Quarter Sales | 186,520,000 | 174,160,000 | 2,020,000 | ||
Last Quarter Net Income | 37,960,000 | 15,330,000 | -18,780,000 | ||
60-Month Beta | 0.79 | 0.90 | 0.96 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.92 on 02/27/25 | 0.75 on 02/25/25 | -0.07 on 02/26/25 | ||
Latest Earnings Date | 05/07/25 | 05/06/25 | 05/13/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 7.04 | 16.92 | 0.00 |